Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors

Annals of Surgical Oncology

Volumn 18, Issue 2, 2011, Pages 559-565

  Rawnaq, Tamina ^a   Kunkel, Miriam ^a   Bachmann, Kai ^a   Simon, Ronald ^a   Zander, Hilke ^a   Brandl, Stephan ^a   Sauter, Guido ^a   Izbicki, Jakob R ^a   Kaifi, Jussuf T ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; MIDKINE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOENZYME TECHNIQUES; LEIOMYOMA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NERVE GROWTH FACTORS; PIPERAZINES; PROGNOSIS; PYRIMIDINES; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951556023     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1191-0     Document Type: Article

References (32)

1. CD Fletcher JJ Berman C Corless F Gorstein J Lasota BJ Longley, et al. 2002 Diagnosis of gastrointestinal stromal tumors: a consensus approach Int J Surg Pathol. 10 81 89 10.1177/106689690201000201 12075401 (Pubitemid 34655094)
2. RP DeMatteo JJ Lewis D Leung SS Mudan JM Woodruff MF Brennan 2000 Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival Ann Surg. 231 51 58 1:STN:280:DC%2BD3c7gtVSmtQ%3D%3D 10.1097/00000658-200001000-00008 10636102 (Pubitemid 30043939)
3. M Miettinen W El-Rifai L HLS J Lasota 2002 Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review Hum Pathol. 33 478 483 10.1053/hupa.2002.124123 12094372 (Pubitemid 34747866)
4. M Miettinen M Majidi J Lasota 2002 Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review Eur J Cancer 38 Suppl 5 S39 S51 10.1016/S0959-8049(02)80602-5 12528772
5. GD Demetri M von Mehren CD Blanke AD Van den Abbeele B Eisenberg PJ Roberts, et al. 2002 Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med. 347 472 480 1:CAS:528: DC%2BD38XmtV2nt7s%3D 10.1056/NEJMoa020461 12181401 (Pubitemid 34879334)
6. CD Fletcher JJ Berman C Corless F Gorstein J Lasota BJ Longley, et al. 2002 Diagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol. 33 459 465 10.1053/hupa.2002.123545 12094370 (Pubitemid 34747864)
7. JF Graadt van Roggen ML van Velthuysen PC Hogendoorn 2001 The histopathological differential diagnosis of gastrointestinal stromal tumours J Clin Pathol. 54 96 102 1:STN:280:DC%2BD3M7jsFSisA%3D%3D 10.1136/jcp.54.2.96 11215292 (Pubitemid 32128408)
8. P Schurr S Wolter JT Kaifi U Reichelt H Kleinhans R Wachowiak, et al. 2006 Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome Clin Cancer Res. 12 5151 5157 1:CAS:528: DC%2BD28XovF2gsL0%3D 10.1158/1078-0432.CCR-05-2083 16951233 (Pubitemid 44453343)
9. K Kadomatsu 2000 Recent progress of midkine research on cancer Nippon Rinsho. 58 1337 1347 1:STN:280:DC%2BD3cvjvVKktw%3D%3D 10879061
10. GE Stoica A Kuo C Powers ET Bowden EB Sale AT Riegel, et al. 2002 Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types J Biol Chem. 277 35990 35998 1:CAS:528:DC%2BD38XnsVCjs78%3D 10.1074/jbc.M205749200 12122009
11. Y Takei K Kadomatsu K Yuasa W Sato T Muramatsu 2005 Morpholino antisense oligomer targeting human midkine: its application for cancer therapy Int J Cancer. 114 490 497 1:CAS:528:DC%2BD2MXhvFKksbs%3D 10.1002/ijc.20781 15578698 (Pubitemid 40279975)
12. S Ikematsu A Yano K Aridome M Kikuchi H Kumai H Nagano, et al. 2000 Serum midkine levels are increased in patients with various types of carcinomas Br J Cancer. 83 701 706 1:CAS:528:DC%2BD3cXntFOhsrY%3D 10.1054/bjoc.2000.1339 10952771
13. K Kadomatsu T Muramatsu 2004 Midkine and pleiotrophin in neural development and cancer Cancer Lett. 204 127 143 1:CAS:528:DC%2BD2cXpsVynsQ%3D%3D 10.1016/S0304-3835(03)00450-6 15013213 (Pubitemid 38167717)
14. C Friedrich N Holtkamp J Cinatl Jr S Sakuma VF Mautner S Wellman, et al. 2005 Overexpression of Midkine in malignant peripheral nerve sheath tumor cells inhibits apoptosis and increases angiogenic potency Int J Oncol. 27 1433 1440 1:CAS:528:DC%2BD2MXht1amtrfO 16211240
15. HC Fiegel JT Kaifi R Wachowiak A Quaas K Aridome K Ichihara-Tanaka, et al. 2008 Midkine is highly expressed in neuroblastoma tissues Pediatr Surg Int. 24 1355 1359 10.1007/s00383-008-2263-0 18956201
16. S Ikematsu A Nakagawara Y Nakamura S Sakuma K Wakai T Muramatsu, et al. 2003 Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas Br J Cancer. 88 1522 1526 1:CAS:528: DC%2BD3sXktVent7w%3D 10.1038/sj.bjc.6600938 12771916 (Pubitemid 36713776)
17. K Mishima A Asai K Kadomatsu Y Ino K Nomura Y Narita, et al. 1997 Increased expression of midkine during the progression of human astrocytomas Neurosci Lett. 233 29 32 1:CAS:528:DyaK2sXmtlChu7Y%3D 10.1016/S0304-3940(97) 00619-8 9324232 (Pubitemid 27402545)
18. H Shimada Y Nabeya S Okazumi H Matsubara K Kadomatsu T Muramatsu, et al. 2003 Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer Oncol Rep. 10 411 414 1:CAS:528:DC%2BD3sXhvFGksLs%3D 12579281
19. K Tanabe M Matsumoto S Ikematsu S Nagase A Hatakeyama T Takano, et al. 2008 Midkine and its clinical significance in endometrial carcinoma Cancer Sci. 99 1125 1130 1:CAS:528:DC%2BD1cXnsVOrs7g%3D 10.1111/j.1349-7006.2008.00796.x 18422745 (Pubitemid 351676623)
20. H Shimada Y Nabeya M Tagawa S Okazumi H Matsubara K Kadomatsu, et al. 2003 Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma Cancer Sci. 94 628 632 1:CAS:528: DC%2BD2cXhs1KgsLk%3D 10.1111/j.1349-7006.2003.tb01494.x 12841873 (Pubitemid 36975019)
21. Y Obata S Kikuchi Y Lin K Yagyu T Muramatsu H Kumai 2005 Serum midkine concentrations and gastric cancer Cancer Sci. 96 54 56 1:CAS:528: DC%2BD2MXhtlamsLg%3D 10.1111/j.1349-7006.2005.00001.x 15649256 (Pubitemid 40310026)
22. JT Kaifi HC Fiegel SL Rafnsdottir K Aridome PG Schurr U Reichelt, et al. 2007 Midkine as a prognostic marker for gastrointestinal stromal tumors J Cancer Res Clin Oncol. 133 431 435 1:CAS:528:DC%2BD2sXls1Sit7s%3D 10.1007/s00432-006- 0180-y 17221186 (Pubitemid 46800663)
23. P Schraml J Kononen L Bubendorf H Moch H Bissig A Nocito, et al. 1999 Tissue microarrays for gene amplification surveys in many different tumor types Clin Cancer Res. 5 1966 1975 1:STN:280:DyaK1MvgtVSmsA%3D%3D 10473073 (Pubitemid 29399245)
24. K Ota H Fujimori M Ueda S Shiniriki M Kudo H Jono, et al. 2008 Midkine as a prognostic biomarker in oral squamous cell carcinoma Br J Cancer. 99 655 662 1:CAS:528:DC%2BD1cXpslWrt78%3D 10.1038/sj.bjc.6604539 18682710
25. S Maeda H Shinchi H Kurahara Y Mataki H Noma K Maemura, et al. 2007 Clinical significance of midkine expression in pancreatic head carcinoma Br J Cancer. 97 405 411 1:CAS:528:DC%2BD2sXotlSgtrg%3D 10.1038/sj.bjc.6603879 17622248 (Pubitemid 47196750)
26. YJ Ren QY Zhang 2006 Expression of midkine and its clinical significance in esophageal squamous cell carcinoma World J Gastroenterol. 12 2006 2010 1:CAS:528:DC%2BD28Xlt1Kgu7s%3D 16610048
27. JT Kaifi A Strelow PG Schurr U Reichelt EF Yekebas R Wachowiak, et al. 2006 L1 (CD171) is highly expressed in gastrointestinal stromal tumors Mod Pathol. 19 399 406 1:CAS:528:DC%2BD28XhsFSmtL4%3D 10.1038/modpathol.3800547 16400320 (Pubitemid 43276994)
28. R Takahashi S Tanaka Y Kitadai M Sumii M Yoshihara K Haruma, et al. 2003 Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach Oncology. 64 266 274 1:CAS:528:DC%2BD3sXivFOht74%3D 10.1159/000069316 12697968 (Pubitemid 36438812)
29. R Takahashi S Tanaka T Hiyama M Ito Y Kitadai M Sumii, et al. 2003 Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach Oncol Rep. 10 797 802 1:CAS:528: DC%2BD3sXltFGlsbs%3D 12792726
30. Y Huang G Cao H Wang Q Wang Y Hou 2007 The expression and location of midkine in gastric carcinomas of Chinese patients Cell Mol Immunol. 4 135 140 1:CAS:528:DC%2BD2sXmsFamtLo%3D 17484808
31. H Maehara T Kaname K Yanagi H Hanzawa I Owan T Kinjou, et al. 2007 Midkine as a novel target for antibody therapy in osteosarcoma Biochem Biophys Res Commun. 358 757 762 1:CAS:528:DC%2BD2sXlvV2qsb8%3D 10.1016/j.bbrc.2007.04. 183 17506984 (Pubitemid 46802456)
32. Q Wang Y Huang Y Ni H Wang Y Hou 2007 siRNA targeting midkine inhibits gastric cancer cells growth and induces apoptosis involved caspase-3, 8, 0 activation and mitochondrial depolarization J Biomed Sci. 14 783 795 1:CAS:528:DC%2BD2sXhsVyju7fO 10.1007/s11373-007-9192-0 17665317 (Pubitemid 47573156)